Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 180

1.

Role of Methadone in Extracorporeal Membrane Oxygenation: Two Case Reports.

Dong E, Fellin R, Ramzy D, Chung JS, Arabia FA, Chan A, Ng D, D'Attellis N, Nurok M.

J Extra Corpor Technol. 2018 Dec;50(4):252-255.

PMID:
30581234
2.

Lipoprotein-X fifty years after its original discovery.

Fellin R, Manzato E.

Nutr Metab Cardiovasc Dis. 2019 Jan;29(1):4-8. doi: 10.1016/j.numecd.2018.09.006. Epub 2018 Sep 26. Review.

PMID:
30503707
3.

Reducing Impact Loading in Runners: A One-Year Follow-up.

Bowser BJ, Fellin R, Milner CE, Pohl MB, Davis IS.

Med Sci Sports Exerc. 2018 Dec;50(12):2500-2506. doi: 10.1249/MSS.0000000000001710.

PMID:
29975300
4.

Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.

D'Erasmo L, Minicocci I, Nicolucci A, Pintus P, Roeters Van Lennep JE, Masana L, Mata P, Sánchez-Hernández RM, Prieto-Matos P, Real JT, Ascaso JF, Lafuente EE, Pocovi M, Fuentes FJ, Muntoni S, Bertolini S, Sirtori C, Calabresi L, Pavanello C, Averna M, Cefalu AB, Noto D, Pacifico AA, Pes GM, Harada-Shiba M, Manzato E, Zambon S, Zambon A, Vogt A, Scardapane M, Sjouke B, Fellin R, Arca M.

J Am Coll Cardiol. 2018 Jan 23;71(3):279-288. doi: 10.1016/j.jacc.2017.11.028. Erratum in: J Am Coll Cardiol. 2018 Mar 6;71(9):1058.

5.

Exceptional Exercise Capacity in an 80-Year-Old Breast Cancer Survivor and Long-Term Sprint Athlete.

Grazzi G, Volpato S, Passaro A, Myers J, Fellin R.

J Am Geriatr Soc. 2015 Dec;63(12):2641-2643. doi: 10.1111/jgs.13843. Epub 2015 Dec 16. No abstract available.

PMID:
26676272
6.

The history of Autosomal Recessive Hypercholesterolemia (ARH). From clinical observations to gene identification.

Fellin R, Arca M, Zuliani G, Calandra S, Bertolini S.

Gene. 2015 Jan 15;555(1):23-32. doi: 10.1016/j.gene.2014.09.020. Epub 2014 Sep 16. Review.

PMID:
25225128
7.

In Memoriam. Obituary: Professor Andrea Mezzetti, MD (1949-2013).

Arca M, Fellin R.

Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):903-4. No abstract available.

PMID:
24936608
8.

Brain-derived neurotrophic factor plasma levels: relationship with dementia and diabetes in the elderly population.

Passaro A, Dalla Nora E, Morieri ML, Soavi C, Sanz JM, Zurlo A, Fellin R, Zuliani G.

J Gerontol A Biol Sci Med Sci. 2015 Mar;70(3):294-302. doi: 10.1093/gerona/glu028. Epub 2014 Mar 12.

PMID:
24621946
9.

Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society.

Soresi M, Noto D, Cefalù AB, Martini S, Vigna GB, Fonda M, Manzato E, Cattin L, Fellin R, Averna MR, Notarbartolo A; Metabolic Syndrome Study Group.

Acta Diabetol. 2013 Apr;50(2):241-9. doi: 10.1007/s00592-012-0406-1. Epub 2012 Jun 9.

PMID:
22684314
10.

PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome.

Passaro A, Dalla Nora E, Marcello C, Di Vece F, Morieri ML, Sanz JM, Bosi C, Fellin R, Zuliani G.

Cardiovasc Diabetol. 2011 Dec 14;10:112. doi: 10.1186/1475-2840-10-112.

11.

Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults.

Volpato S, Ferrucci L, Secchiero P, Corallini F, Zuliani G, Fellin R, Guralnik JM, Bandinelli S, Zauli G.

Atherosclerosis. 2011 Apr;215(2):452-8. doi: 10.1016/j.atherosclerosis.2010.11.004. Epub 2010 Nov 11.

12.

Pharmacotherapy of dyslipidemias in the adult population.

Vigna GB, Fellin R.

Expert Opin Pharmacother. 2010 Dec;11(18):3041-52. doi: 10.1517/14656566.2010.513116. Epub 2010 Oct 19. Review.

PMID:
20958118
13.

Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance.

Zuliani G, Galvani M, Maggio M, Volpato S, Bandinelli S, Corsi AM, Lauretani F, Cherubini A, Guralnik JM, Fellin R, Ferrucci L.

Atherosclerosis. 2010 Nov;213(1):319-24. doi: 10.1016/j.atherosclerosis.2010.08.074.

14.

Predictive value of the Short Physical Performance Battery following hospitalization in older patients.

Volpato S, Cavalieri M, Sioulis F, Guerra G, Maraldi C, Zuliani G, Fellin R, Guralnik JM.

J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):89-96. doi: 10.1093/gerona/glq167. Epub 2010 Sep 22.

15.

Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study).

Volpato S, Vigna GB, McDermott MM, Cavalieri M, Maraldi C, Lauretani F, Bandinelli S, Zuliani G, Guralnik JM, Fellin R, Ferrucci L.

Am J Cardiol. 2010 Jun 15;105(12):1825-30. doi: 10.1016/j.amjcard.2010.01.370. Epub 2010 Apr 27.

16.

The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism.

Volpato S, Vigna GB, Fellin R.

Acta Biomed. 2010;81 Suppl 1:95-9. Review.

PMID:
20518198
17.

Hypercholesterolemia and the ageing subject.

Vigna GB, Zuliani G, Fellin R.

Eur J Intern Med. 2010 Jun;21(3):e19; author reply e20. doi: 10.1016/j.ejim.2009.12.009. Epub 2010 Jan 12. No abstract available.

PMID:
20493406
18.

Type 2 diabetes and risk for functional decline and disability in older persons.

Volpato S, Maraldi C, Fellin R.

Curr Diabetes Rev. 2010 May;6(3):134-43. Review.

PMID:
20380626
19.

Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study.

Zuliani G, Cavalieri M, Galvani M, Volpato S, Cherubini A, Bandinelli S, Corsi AM, Lauretani F, Guralnik JM, Fellin R, Ferrucci L.

J Gerontol A Biol Sci Med Sci. 2010 May;65(5):559-64. doi: 10.1093/gerona/glq026. Epub 2010 Mar 18.

20.

The role of polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias.

Zuliani G, Galvani M, Leitersdorf E, Volpato S, Cavalieri M, Fellin R.

Curr Pharm Des. 2009;15(36):4087-93.

PMID:
20041810

Supplemental Content

Loading ...
Support Center